WallStreetZen

NASDAQ: SNY
Sanofi Earnings & Revenue

SNY past earnings growth

How has SNY's earnings growth performed historically?
Company
-36.56%
Industry
12.1%
Market
38.02%
SNY's earnings have grown slower (-9.05% per year) than the US Drug Manufacturers - General industry average (6.08%)
Performance
SNY's earnings have grown slower (-9.05% per year) than the US market average (28.47%)
Performance
SNY's earnings growth is slowing down - its growth over the last year (-36.56%) is below its 5-year compound annual rate (-9.05%)
Performance

SNY past revenue growth

How has SNY's revenue growth performed historically?
Company
3.11%
Industry
8.77%
Market
16.24%
SNY's revenue has grown slower (1.77% per year) than the US Drug Manufacturers - General industry average (4.22%)
Performance
SNY's revenue has grown slower (1.77% per year) than the US market average (16.12%)
Performance
SNY's revenue growth is accelerating - its growth over the last year (3.11%) is above its 5-year compound annual rate (1.77%)
Performance

SNY earnings and revenue history

Current Revenue
$42.3B
Current Earnings
$3.2B
Current Profit Margin
7.5%
SNY's has not demonstrated consistent long-term earnings growth over the past 10 years (-56.47%)
Performance

SNY Return on equity

Current Company
4.8%
Current Industry
36.3%
Current Market
14.9%
SNY's Return on Equity (4.8%) shows a company that is not efficient at transforming shareholder equity into returns
Performance

SNY Return on assets

Current Company
2.5%
Current Industry
9.4%
Current Market
6.8%
SNY is generating lower Return on Assets (2.5%) than the US Drug Manufacturers - General industry average (8.26%)
Performance

SNY Return on capital employed

Current Company
3.67%
Current Industry
14.4%
SNY's ability to generate Return on Capital (3.67%) has decreased compared to 3 years ago (7.89%)
Performance

Sanofi Earnings & Revenue FAQ

What was SNY's earnings growth in the past year?

As of Q1 2021, Sanofi's earnings has grown -36.56% year over year. This is 48.66 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 12.1%. Sanofi's earnings in the past year totalled $3.15 billion.

What was SNY's revenue growth in the past year?

As of Q1 2021, Sanofi's revenue has grown 3.11% year over year. This is 5.66 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 8.77%. Sanofi's revenue in the past year totalled $42.28 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics